EUVIMEDEUVIMED entdecken
Crossref

Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort

Katrin Ritzel iD, Julia Fazel, Leah August, Vanessa Fedtke, Elisabeth Nowak, Frederick Vogel iD, Leah Braun iD, Stephanie Zopp, Cornelia Then iD, Heike Künzel, Nicole Reisch iD, Petra Zimmermann und 6 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Katrin Ritzel und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine IV, LMU University Hospital, LMU Munich, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Cushing Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Normalization of hypercortisolism is essential to reduce morbidity and mortality in patients with Cushing's syndrome (CS). The aim of this analysis was to assess biochemical control rates in patients with Cushing's disease (CD), ectopic Cushing's syndrome (ECS), and adrenal Cushing's syndrome (ACS).

Methods

Patients with confirmed CS (n = 296) treated in a single tertiary care center were retrospectively analyzed (185 CD, 27 ECS, 84 uni- and bilateral ACS).

Results

First-line treatment led to biochemical control in 82% of the patients. Time to biochemical control (median, interquartile range) was longer in CD (11.0 weeks, 5.6-29.8; P < .05) than in ACS (7.7 weeks, 4.1-17.1) and ECS (5.6 weeks, 4.1-23.3). Disease persistence or recurrence after first-line therapy was observed more often in CD (24% and 18%; P < .05) than in ECS (15% and 15%) and ACS (6% and 4%). Total time in hypercortisolism since diagnosis was significantly shorter in patients with CD diagnosed since 2013, after specialized patient care was implemented, compared to patients diagnosed before 2013 (13.5 weeks vs 26.1 weeks; P < .0070). Control of hypercortisolism at last follow-up (76 months, 38-163) was achieved in 94% of patients with ACS, 100% of patients with ECS, and 92% of patients with CD.

Conclusion

Biochemical control can be achieved in most patients with different subtypes of CS within a reasonable time frame. Control of hypercortisolism has improved over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomePituitary ACTH HypersecretionAgedAdrenocorticotropic HormoneHydrocortisoneCohort StudiesRecurrence

Stichwörter der Autor:innen

ACTHCushing's diseaseadrenal Cushing's syndromeadrenalectomybiochemical controlcortisolectopic Cushing's syndromehypercortisolismmedical treatmentpituitary surgeryradiotherapy

Substanzen

Adrenocorticotropic HormoneHydrocortisone

Autor:innen und Institutionen

  • Department of Medicine IV, LMU University Hospital, LMU Munich, 80336 Munich, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
  • Department of Neurosurgery, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
  • Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zürich and University of Zurich, 8091 Zurich, Switzerland.
  • The LOOP Zurich-Medical Research Center, 8044 Zurich, Switzerland.

ORCID-Profile: Katrin Ritzel, Frederick Vogel, Leah Braun, Cornelia Then, Nicole Reisch, Jun Thorsteinsdottir, Martin Bidlingmaier, Felix Beuschlein, Martin Reincke, German Rubinstein

Zitieren

APA

Ritzel, K., Fazel, J., August, L., Fedtke, V., Nowak, E., Vogel, F., Braun, L., Zopp, S., Then, C., Künzel, H., Reisch, N., Zimmermann, P., Thorsteinsdottir, J., Schopohl, J., Bidlingmaier, M., Beuschlein, F., Reincke, M., & Rubinstein, G. (2025). Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae337

Vancouver

Ritzel K, Fazel J, August L, Fedtke V, Nowak E, Vogel F, et al. Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae337

BibTeX
@article{Ritzel2025,
  author = {Ritzel, Katrin and Fazel, Julia and August, Leah and Fedtke, Vanessa and Nowak, Elisabeth and Vogel, Frederick and Braun, Leah and Zopp, Stephanie and Then, Cornelia and Künzel, Heike and Reisch, Nicole and Zimmermann, Petra and Thorsteinsdottir, Jun and Schopohl, Jochen and Bidlingmaier, Martin and Beuschlein, Felix and Reincke, Martin and Rubinstein, German},
  title = {Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae337}
}
Kostenlos starten →